Cancer of Pancreas: Clinical Trials

65 trials for Cancer of Pancreas, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 15 unknown, 10 terminated, 6 recruiting. 19 Not applicable, 17 Phase 2, 15 Phase 1, 3 Phase 4, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable19Completed 11, Unknown 3, Terminated 2, Active not recruiting 1, Recruiting 1, Withdrawn 1
Phase 217Terminated 6, Unknown 6, Completed 4, Recruiting 1
Phase 115Terminated 6, Completed 4, Active not recruiting 2, Unknown 2, Not yet recruiting 1
Phase 43Completed 2, Unknown 1
Phase 32Completed 1, Unknown 1
Early Phase 11Withdrawn 1

Follow Cancer of Pancreas: new trials by email Literature Review of Cancer of Pancreas trials Research Report on Cancer of Pancreas

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Wet Heparinized Suction for Abdominal Cancer
wet heparinzed suction, Microsieve, No heparin flush - Cancer of Pancreas, Cancer of Stomach
Not applicableWithdrawnH. Lee Moffitt Cancer Center and Research Institute2025-11-252026-09-17
LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TUMORS
No Interventions - Cancer of Rectum, Cancer of Pancreas
Active not recruitingHospital do Coracao2732025-01-102025-04-27
Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients
Analyze of GemCore status - Cancer Of Pancreas
Not applicableRecruitingInstitut Paoli-Calmettes1002024-05-232026-09-29
Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors
STI-1386 - Cancer, Cancer of Pancreas
Phase 1Not yet recruitingSorrento Therapeutics, Inc.362023-08-012023-04-12
Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
Non-Human Subject Research study. - Cancer of Pancreas
RecruitingUniversity of Central Florida242023-05-242024-12-06
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
CBP-1019 - Cancer, Breast, Cancer, Lung
Phase 1 / Phase 2UnknownCoherent Biopharma (Hefei) Co., Ltd.2602023-03-142024-08-26
A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas
Capecitabine, follow up - Cancer of Pancreas
Phase 2UnknownMenoufia University402022-09-112022-10-04
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
HBI-2438 - Lung Cancer, Non Small Cell Lung Cancer
Phase 1Active not recruitingHUYABIO International, LLC.442022-08-012025-09-24
Lidocaine Infusion With ERAS Protocol for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity.
Lidocaine IV, saline IV - ERAS, Lidocaine
Not applicableCompletedAlexandria University302022-04-202024-08-21
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
NUV-868, Olaparib, Enzalutamide - Advanced Solid Tumor, Ovarian Cancer
Phase 1TerminatedNuvation Bio Inc.822022-03-292025-11-06
Iconographic Registry of Pancreatobiliary Endoscopy Procedures
Pancreas Neoplasm, Cancer of Pancreas
RecruitingIRCCS San Raffaele120002022-03-282026-09-08
Home-based Prehabilitation in Pancreatic Resection
Home-based prehabilitation program - Preoperative Physical Exercise Training, Aerobic Capacity
Not applicableCompletedNicole Hildebrand452022-01-012024-08-05
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
HBI-2376 - Non Small Cell Lung Cancer, Colorectal Cancer
Phase 1Active not recruitingHUYABIO International, LLC.422021-12-132025-09-24
Multi-omics Characterization of Pancreatic Neuroendocrine Tumors and Carcinomas
Cancer of Pancreas
UnknownUniversity Hospital, Strasbourg, France3002021-12-012022-02-10
Echo-endoscopy Biopsy Impact on the Circulating Tumor Cell Level
Blood sample in portal vein - Cancer of Pancreas
Not applicableUnknownInstitut Paoli-Calmettes422021-11-112024-04-09
Onco-primary Care Networking to Support TEAM-based Care
iGuide Intervention (Self-guided), iGuide 2 Intervention (Tailored/Targeted), Control - Blood Pressure, Hypertension
Not applicableActive not recruitingDuke University3132021-06-142026-02-20
Pancreatico Enteric Anastomosis Post Pancreaticoduodenectomy
Blumgart Anastomosis, Cattell Warren Anastomosis - Cancer of Pancreas
Not applicableUnknownCairo University902021-06-122021-12-20
The Registry of Oncology Outcomes Associated With Testing and Treatment
Biomarker Testing (L), Systemic Treatment (T), Patient Reported Outcomes (P) - Adenocarcinoma, Adenocystic Carcinoma
CompletedTaproot Health1672021-05-052024-12-18
Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN)
Gemcitabine fluorouracil - Cancer of Pancreas, Chemotherapy Effect
Phase 2CompletedMenoufia University482021-02-202022-08-08
Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer
Pre-operative stereotactic ablative body radiotherapy - Cancer of Pancreas
Not applicableCompletedCCTU- Cancer Theme102020-10-262026-04-20

Showing 20 of 65. Sign in to see all of them.

Narrower conditions

Pancreatic Neoplasms (65)  ·  Neoplasms (16)  ·  Colonic Neoplasms (11)  ·  Liver Neoplasms (10)  ·  Stomach Neoplasms (10)  ·  Esophageal Neoplasms (9)  ·  Breast Neoplasms (8)  ·  Lung Neoplasms (7)  ·  Prostatic Neoplasms (7)  ·  Colorectal Neoplasms (6)  ·  Ovarian Neoplasms (6)  ·  Rectal Neoplasms (6)  ·  Carcinoma, Non-Small-Cell Lung (5)  ·  Cholangiocarcinoma (5)  ·  Glioblastoma (5)

Broader conditions

Digestive System Diseases (65)  ·  Digestive System Neoplasms (65)  ·  Endocrine System Diseases (65)  ·  Neoplasms by Site (65)  ·  Pancreatic Diseases (65)  ·  Endocrine Gland Neoplasms (64)  ·  Neoplasms (49)  ·  Gastrointestinal Diseases (18)  ·  Gastrointestinal Neoplasms (18)  ·  Intestinal Diseases (15)  ·  Intestinal Neoplasms (15)  ·  Neoplasms by Histologic Type (14)  ·  Colonic Diseases (13)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Liver Diseases (11)

Interventions

Gemcitabine (8)  ·  Fluorouracil (5)  ·  Oxaliplatin (5)  ·  130-nm albumin-bound paclitaxel (4)  ·  Irinotecan (4)  ·  Leucovorin (4)  ·  Albumin-Bound Paclitaxel (3)  ·  Anesthesia, Epidural (2)  ·  Anesthesia, General (2)  ·  Capecitabine (2)  ·  Ethanol (2)  ·  Radiosurgery (2)  ·  Acupuncture Therapy (1)  ·  Ascorbic Acid (1)  ·  Bevacizumab (1)

Sponsors

Washington University School of Medicine (4)  ·  Fudan University (2)  ·  HUYABIO International, LLC. (2)  ·  Institut Paoli-Calmettes (2)  ·  Menoufia University (2)  ·  Nanjing Medical University (2)  ·  National Cancer Institute (NCI) (2)  ·  University of Texas Southwestern Medical Center (2)  ·  AdventHealth (1)  ·  Alexandria University (1)  ·  Amgen (1)  ·  Assiut University (1)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  BioXcel Therapeutics Inc (1)  ·  CCTU- Cancer Theme (1)

Countries

United States (30)  ·  China (6)  ·  Egypt (5)  ·  France (5)  ·  United Kingdom (5)  ·  Italy (4)  ·  Hong Kong (3)  ·  Puerto Rico (3)  ·  Australia (2)  ·  Belgium (2)  ·  Brazil (2)  ·  Denmark (2)  ·  Hungary (2)  ·  Netherlands (2)  ·  Poland (2)

Top investigators

Changhong Miao (2)  ·  Qianjin Liu (2)  ·  Yi Miao, Prof. (2)  ·  Alberto Bessudo, MD (1)  ·  Alla Khashper, MD (1)  ·  Andrea Wang-Gillam, M.D., Ph.D. (1)  ·  Anthony Maraveyas (1)  ·  Anthony Shields, M.D. PhD (1)  ·  Ashwin Somasundaram, MD (1)  ·  Bassem Amr, MBBS (1)  ·  BioXcel MM, MD (1)  ·  Carolyn Y Fang, PhD (1)  ·  David Stell, MBBS, PhD (1)  ·  Egidijus Semenas, MD, PhD (1)  ·  Ehab A Abdulmaksoud, master (1)

Results publications

PMID 15886696, PMID 16083707, PMID 17872573, PMID 19111249, PMID 21458985, PMID 21654538, PMID 24840647, PMID 26492440, PMID 26777407, PMID 27475674, PMID 28108468, PMID 28270136, PMID 28939558, PMID 29149611, PMID 29374667, PMID 31521134, PMID 32939319, PMID 33444177, PMID 33996579, PMID 34794388, PMID 35697547, PMID 36427020, PMID 37676715, PMID 39369582, PMID 39462835, PMID 40652824

NIH funding

2016 (1), P01CA217797 (1), P30CA086862 (1), P50CA196510 (1), U01CA140206 (1)